Literature DB >> 1683333

[Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients].

E Klieser1, E Lehmann, J Tegeler.   

Abstract

To assess the efficiency/risk ratio, fixed doses of zotepine and haloperidol were compared by means of a double-blind study in acute schizophrenics over a 4-week period. The assessment tools were BPRS, CGI, and the Simpson-Angus scale for the extrapyramidal disturbances, and a free report on side effects. No differences between the groups were found in respect of efficacy. According to the Simpson-Angus scale, the patients who had been treated with zotepine achieved better values, this being a general trend. There were significant differences according to the free report on side effects. Especially at onset of treatment, the patients treated with zotepine complained of tiredness. Partly marked extrapyramidal disturbances were seen in the patients who had been treated with haloperidol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683333     DOI: 10.1055/s-2007-1000729

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  6 in total

Review 1.  Zotepine versus other atypical antipsychotics for schizophrenia.

Authors:  Selvizhi Subramanian; Christine Rummel-Kluge; Heike Hunger; Franziska Schmid; Sandra Schwarz; Werner Kissling; Stefan Leucht; Katja Komossa
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

Review 2.  Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomes.

Authors:  W W Fleischhacker; M Hummer
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 3.  Zotepine for schizophrenia.

Authors:  P DeSilva; M Fenton; J Rathbone
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

4.  Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats.

Authors:  W F Gattaz; B Schummer; S Behrens
Journal:  J Neural Transm Gen Sect       Date:  1994

Review 5.  Management of the negative symptoms of schizophrenia: new treatment options.

Authors:  Hans-Jürgen Möller
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

6.  Tolerability of zotepine in Indian patients: Preliminary experience.

Authors:  Ram Jeevan Bishnoi; Venu Gopal Jhanwar
Journal:  Ind Psychiatry J       Date:  2010-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.